Short Interest in Smith & Nephew plc (NYSE:SNN) Increases By 28.4%

Smith & Nephew plc (NYSE:SNN) was the recipient of a large growth in short interest in November. As of November 15th, there was short interest totalling 3,120,000 shares, a growth of 28.4% from the October 31st total of 2,430,000 shares. Based on an average trading volume of 799,500 shares, the short-interest ratio is presently 3.9 days. Approximately 0.7% of the company’s stock are sold short.

Smith & Nephew Stock Performance

SNN stock opened at $25.78 on Monday. Smith & Nephew has a twelve month low of $23.65 and a twelve month high of $31.72. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. The business has a 50 day moving average of $27.58 and a 200 day moving average of $27.90.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Berenberg Bank lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Wednesday, November 6th. StockNews.com lowered Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, November 12th. Finally, Deutsche Bank Aktiengesellschaft lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Friday, November 1st.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SNN. Brandes Investment Partners LP boosted its stake in Smith & Nephew by 20.5% during the 2nd quarter. Brandes Investment Partners LP now owns 1,373,051 shares of the medical equipment provider’s stock valued at $34,002,000 after purchasing an additional 233,293 shares during the last quarter. River Road Asset Management LLC purchased a new stake in Smith & Nephew during the 3rd quarter valued at $38,588,000. Bank of Montreal Can boosted its stake in Smith & Nephew by 355.8% during the 2nd quarter. Bank of Montreal Can now owns 1,235,916 shares of the medical equipment provider’s stock valued at $31,059,000 after purchasing an additional 964,762 shares during the last quarter. Hsbc Holdings PLC boosted its stake in Smith & Nephew by 18.9% during the 2nd quarter. Hsbc Holdings PLC now owns 548,691 shares of the medical equipment provider’s stock valued at $13,607,000 after purchasing an additional 87,360 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Smith & Nephew by 58.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 524,602 shares of the medical equipment provider’s stock valued at $12,995,000 after purchasing an additional 193,046 shares during the last quarter. Institutional investors own 25.64% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.